Reaktionsgleichung
[OH:1][C:2]([C:5]1[N:6]=[C:7]([CH2:13][CH2:14][CH3:15])[NH:8][C:9]=1[C:10]([OH:12])=[O:11])([CH3:4])[CH3:3].Br[CH:17]1[C:26]2[C:21](=[CH:22][CH:23]=[CH:24][CH:25]=2)[C:19](=[O:20])[O:18]1>>[OH:1][C:2]([C:5]1[N:6]=[C:7]([CH2:13][CH2:14][CH3:15])[NH:8][C:9]=1[C:10]([O:12][CH:17]1[C:26]2[C:21](=[CH:22][CH:23]=[CH:24][CH:25]=2)[C:19](=[O:20])[O:18]1)=[O:11])([CH3:4])[CH3:3]Komponenten
3
Versuchsvorschrift
Following a procedure similar to that described in Preparation 31, but using 1.06 g of 4-(1-hydroxy-1-methylethyl)-2-propylimidazole-5-carboxylic acid [prepared as described in Preparation 22(i)] and 1.15 g of 3-bromophthalide, 1.63 g of the title compound were obtained as an amorphous solid.
Aufarbeitung
- customthat described in Preparation 31
Quellen und Nachweise
- ORD-Eintrag
- ord-26302c2567c549ef8a5f2b6afc555040
- Quelldatensatz
- uspto-grants-1997_04
- Patentnummer
- US05616599
Verknüpfte Notizen
Wird geladen…